[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE602005025083D1 - - Google Patents

Info

Publication number
DE602005025083D1
DE602005025083D1 DE602005025083T DE602005025083T DE602005025083D1 DE 602005025083 D1 DE602005025083 D1 DE 602005025083D1 DE 602005025083 T DE602005025083 T DE 602005025083T DE 602005025083 T DE602005025083 T DE 602005025083T DE 602005025083 D1 DE602005025083 D1 DE 602005025083D1
Authority
DE
Germany
Prior art keywords
amphiphile
compositions
component
structure forming
lamellar particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025083T
Other languages
English (en)
Inventor
Markus Johnsson
Fredrik Tiberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Camurus AB
Original Assignee
Camurus AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0401515.2A external-priority patent/GB0401515D0/en
Priority claimed from GB0407936A external-priority patent/GB0407936D0/en
Application filed by Camurus AB filed Critical Camurus AB
Publication of DE602005025083D1 publication Critical patent/DE602005025083D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005025083T 2004-01-23 2005-01-21 Active DE602005025083D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0401515.2A GB0401515D0 (en) 2004-01-23 2004-01-23 Compositions
GB0407936A GB0407936D0 (en) 2004-04-07 2004-04-07 Compositions
PCT/GB2005/000202 WO2005070394A2 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions

Publications (1)

Publication Number Publication Date
DE602005025083D1 true DE602005025083D1 (de) 2011-01-13

Family

ID=34809883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025083T Active DE602005025083D1 (de) 2004-01-23 2005-01-21

Country Status (8)

Country Link
US (1) US8182834B2 (de)
EP (1) EP1713446B1 (de)
JP (1) JP4966018B2 (de)
AT (1) ATE489942T1 (de)
CA (1) CA2554052C (de)
DE (1) DE602005025083D1 (de)
PL (1) PL1713446T3 (de)
WO (1) WO2005070394A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005324794C1 (en) * 2003-11-07 2010-12-02 Camurus Ab Somatostatin analogue formulations
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
EP1845942B1 (de) * 2005-01-14 2014-04-09 Camurus Ab Gnrh-analog-formulierungen
ATE462409T1 (de) 2005-01-14 2010-04-15 Camurus Ab Topische bioadhäsive formulierungen
EP1843751B1 (de) 2005-01-21 2020-09-30 Camurus Ab Pharmazeutische lipid-zusammensetzungen
CA2609810C (en) 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
AU2006346369B2 (en) 2005-07-18 2013-02-21 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
SG10201607909WA (en) 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
BRPI0719756A2 (pt) 2006-12-01 2014-01-21 Anterios Inc Nanopartículas de entidades anfifílicas
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
ES2382890T3 (es) * 2007-06-19 2012-06-14 Neubourg Skin Care Gmbh & Co. Kg DMS (derma membrane structure) en cremas de espuma.
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
PT104158B (pt) * 2008-08-18 2011-02-24 Univ Do Minho Aplicação da monooleína como novo lípido adjuvante em lipofecção
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
BR112014013691A2 (pt) 2011-12-05 2017-06-13 Camurus Ab pré-formulação, métodos para distribuição de um agente ativo de peptídeo, para a preparação de uma composição cristalina líquida, de tratamento ou profilaxia de um sujeito, processo para a formação de uma pré-formulação, uso de uma mistura cristalina não líquida de baixa viscosidade, dispositivo de administração de pré-preenchido, e, kit
AU2013265210B2 (en) 2012-05-25 2016-09-15 Camurus Ab Somatostatin receptor agonist formulations
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3938317A1 (de) 2019-03-15 2022-01-19 Saudi Arabian Oil Company Massensynthese von janus-nanomaterialien
US11422285B2 (en) 2020-06-17 2022-08-23 Saudi Arabian Oil Company Nanofluidic chips as micromodels for carbonate reservoirs
US11827850B2 (en) 2020-07-24 2023-11-28 Saudi Arabian Oil Company Enhanced oil recovery with janus nanoparticles
WO2022051628A1 (en) 2020-09-03 2022-03-10 Saudi Arabian Oil Company Injecting multiple tracer tag fluids into a wellbore
US11660595B2 (en) 2021-01-04 2023-05-30 Saudi Arabian Oil Company Microfluidic chip with multiple porosity regions for reservoir modeling
US11534759B2 (en) 2021-01-22 2022-12-27 Saudi Arabian Oil Company Microfluidic chip with mixed porosities for reservoir modeling
US12000278B2 (en) 2021-12-16 2024-06-04 Saudi Arabian Oil Company Determining oil and water production rates in multiple production zones from a single production well

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133391T3 (es) 1991-10-04 1999-09-16 Gs Dev Ab Particulas, metodo para preparar dichas particulas y usos de las mismas.
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
HU225069B1 (en) 1997-09-09 2006-06-28 Lyotropic Therapeutics Coated particles, methods of making and using
CA2329768C (en) * 1998-04-27 2008-06-10 Opperbas Holding B.V. Pharmaceutical composition comprising factor viii and neutral liposomes
US6537575B1 (en) 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
WO2005014163A1 (en) 2003-08-04 2005-02-17 Camurus Ab Method for loading amphiphile particles with active agents
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition

Also Published As

Publication number Publication date
WO2005070394A2 (en) 2005-08-04
ATE489942T1 (de) 2010-12-15
CA2554052C (en) 2013-10-22
PL1713446T3 (pl) 2011-05-31
WO2005070394A3 (en) 2006-01-26
EP1713446A2 (de) 2006-10-25
US8182834B2 (en) 2012-05-22
JP2007518784A (ja) 2007-07-12
EP1713446B1 (de) 2010-12-01
JP4966018B2 (ja) 2012-07-04
US20080206317A1 (en) 2008-08-28
CA2554052A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
DE602005025083D1 (de)
SG161261A1 (en) Lactam compounds and their use as pharmaceuticals
WO2007051811A3 (en) Pharmaceutical use of substituted amides
NO20062798L (no) Anvendelse av en vannholdig dispersjon av i det minste en bio-nedbrytbar polymer inneholdende i det minste et stabiliseringsmiddel for fremstilling av en vanndig filmdannende sammensetning
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
MX2007003162A (es) Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa.
WO2006020598A3 (en) Amido compounds and their use as pharmaceuticals
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
WO2006013369A3 (en) Compositions forming non-lamellar dispersions
WO2007022023A3 (en) Film forming spreading agents
SG163518A1 (en) Amido compounds and their use as pharmaceuticals
MX2009009623A (es) Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2006012227A3 (en) Amido compounds and their use as pharmaceuticals
WO2007085833A3 (en) Pyrimidine derivatives
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
WO2007043057A3 (en) Compositions for nasal delivery
HK1135609A1 (en) Formation of medically useful gels comprising microporous particles and methods of use
EP1340755A4 (de) Mittel mit wirkung gegen helicobacter
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2004092100A8 (en) Indene derivatives as pharmaceutical agents
GB0401513D0 (en) Compositions
WO2007065625A3 (en) Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations